Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE3
40000 participants
INTERVENTIONAL
2004-10-31
2006-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
First Breath: Neonatal Resuscitation in Developing Countries
NCT00136708
Impact of the PREEMI Package on Neonatal Mortality
NCT03923023
Mobile Virtual Simulation Training in Essential Newborn Care for Healthcare Workers in Low and Middle Income Countries
NCT05551312
Evaluation of Use of Plastic Bags to Prevent Neonatal Hypothermia-Part V
NCT01604460
Verbal Autopsy to Assess Early Neonatal Death and Stillbirth
NCT00640055
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The primary outcome will be a decrease in neonatal 7-day mortality following the NRP training when compared to the ENC-only time period. Secondary outcomes will include neonatal mortality due to perinatal asphyxia, mortality or hypoxic ischemic encephalopathy (HIE) at 7 days, need for advanced resuscitation, Apgar scores at 5 minutes, sustainability of the program, as well as providers' self efficacy, competence, and performance in neonatal resuscitation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
DIAGNOSTIC
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neonatal Resuscitation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infants who are born at participating health centers in Lusaka and Ndola, Zambia
* No lethal malformations
Exclusion Criteria
* Infants with suspected/confirmed lethal malformations (e.g. anencephaly, Trisomy 13 or 18, or cyanotic or left sided congenital heart disease that will not be repaired)
* Any infant who is transported/brought to the center after delivery
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Global Network for Women's and Children's Health Research
OTHER
Bill and Melinda Gates Foundation
OTHER
Fogarty International Center of the National Institute of Health
NIH
National Center for Complementary and Integrative Health (NCCIH)
NIH
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
National Cancer Institute (NCI)
NIH
RTI International
OTHER
University of Alabama at Birmingham
OTHER
NICHD Global Network for Women's and Children's Health
NETWORK
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Waldemar A Carlo, MD
Role: PRINCIPAL_INVESTIGATOR
University of Alabama at Birmingham
Elwyn Chomba, MBChB, DCH, MRCP
Role: PRINCIPAL_INVESTIGATOR
University Teaching Hospital, Lusaka, Zambia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Zambia
Lusaka, , Zambia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Global Network for Women's and Children's Health Research
Research Triangle Institute International
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GN 03
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.